Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 9, Issue 5, Pages 467-483
Publisher
Informa Healthcare
Online
2014-03-18
DOI
10.1517/17460441.2014.897324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stevens-Johnson Syndrome associated with mogamulizumab treatment of adult T-cell leukemia / lymphoma
- (2013) Takashi Ishida et al. CANCER SCIENCE
- CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4
- (2013) Kandace Bonner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Compartmentalized chemokine-dependent regulatory T-cell inhibition of allergic pulmonary inflammation
- (2013) Roshi Afshar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation
- (2013) Krisztian Gaspar et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4
- (2013) Zamaneh Mikhak et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Synthesis and Structure–Activity Relationships of Indazole Arylsulfonamides as Allosteric CC-Chemokine Receptor 4 (CCR4) Antagonists
- (2013) Panayiotis A. Procopiou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study
- (2013) Anthony Cahn et al. BMC Pharmacology & Toxicology
- Discovery and structure–activity relationships of urea derivatives as potent and novel CCR3 antagonists
- (2012) Aiko Nitta et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H1 antagonists. Part II: Optimising in vivo clearance
- (2012) Mark Furber et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H1 antagonists. Part I
- (2012) Mark Furber et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation
- (2012) Panayiotis A. Procopiou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Scaffold-hopping with zwitterionic CCR3 antagonists: Identification and optimisation of a series with good potency and pharmacokinetics leading to the discovery of AZ12436092
- (2012) Ash Bahl et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonists
- (2012) Aiko Nitta et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The discovery of CCR3/H1 dual antagonists with reduced hERG risk
- (2012) Ash Bahl et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The estimated prevalence and incidence of late stage age related macular degeneration in the UK
- (2012) Christopher G Owen et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- CCR3 induced-p42/44 MAPK activation protects against staurosporine induced-DNA fragmentation but not apoptosis in airway smooth muscle cells
- (2012) L. J. Markwick et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Mogamulizumab
- (2012) Joshuan M. Subramaniam et al. DRUGS
- An Antagonist for CCR4 Alleviates Murine Allergic Rhinitis by Intranasal Administration
- (2012) Hui Qi et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Chemokine Receptor Antagonists
- (2012) James Pease et al. JOURNAL OF MEDICINAL CHEMISTRY
- Marketing approval of mogamulizumab
- (2012) Alain Beck et al. mAbs
- Asthma phenotypes: the evolution from clinical to molecular approaches
- (2012) Sally E Wenzel NATURE MEDICINE
- Targeting chemokine receptors in allergic disease
- (2011) James E. Pease BIOCHEMICAL JOURNAL
- A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens
- (2011) H. Pere et al. BLOOD
- Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4
- (2011) O. Kaminuma et al. CLINICAL AND EXPERIMENTAL ALLERGY
- TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge
- (2011) H. Imaoka et al. CLINICAL AND EXPERIMENTAL ALLERGY
- CC and CXC Chemokines Induce Airway Smooth Muscle Proliferation and Survival
- (2011) Rabih Halwani et al. JOURNAL OF IMMUNOLOGY
- Monoclonal antibodies for the treatment of asthma
- (2011) Matthew C. Catley et al. PHARMACOLOGY & THERAPEUTICS
- CCR3 and Choroidal Neovascularization
- (2011) Yiwen Li et al. PLoS One
- Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis
- (2011) Maria C. Lebre et al. PLoS One
- A Novel CC Chemokine Receptor 4 Antagonist RS-1269 Inhibits Ovalbumin-Induced Ear Swelling and Lipopolysaccharide-Induced Endotoxic Shock in Mice
- (2010) Yasuhiro Nakagami et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- RS-1748, a Novel CC Chemokine Receptor 4 Antagonist, Inhibits Ovalbumin-Induced Airway Inflammation in Guinea Pigs
- (2010) Yasuhiro Nakagami et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- The eosinophil and airway remodelling in asthma
- (2010) Per Venge Clinical Respiratory Journal
- Small Molecule Antagonists of Chemokine Receptors - is Promiscuity a Virtue?
- (2010) James E. Pease et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Eotaxin-3/CC Chemokine Ligand 26 Is a Functional Ligand for CX3CR1
- (2010) T. Nakayama et al. JOURNAL OF IMMUNOLOGY
- CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages
- (2010) C. A. Gleissner et al. JOURNAL OF IMMUNOLOGY
- Chemokine Receptor 4 Plays a Key Role in T Cell Recruitment into the Airways of Asthmatic Patients
- (2010) P. Vijayanand et al. JOURNAL OF IMMUNOLOGY
- Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice
- (2010) Rodrigo Guabiraba et al. PLoS One
- Novel CC chemokine receptor 4 antagonist RS-1154 inhibits ovalbumin-induced ear swelling in mice
- (2009) Yasuhiro Nakagami et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CCR3 antagonists: a survey of the patent literature
- (2009) Leyi Gong et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Chemokine receptor antagonists: Part 1
- (2009) James E Pease et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- CCR3 is a target for age-related macular degeneration diagnosis and therapy
- (2009) Atsunobu Takeda et al. NATURE
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
- (2009) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibitory Effect of the New Orally Active CCR4 Antagonist K327 on CCR4+CD4+ T Cell Migration into the Lung of Mice with Ovalbumin-Induced Lung Allergic Inflammation
- (2009) Takashi Sato et al. PHARMACOLOGY
- Antisense Therapy against CCR3 and the Common Beta Chain Attenuates Allergen-induced Eosinophilic Responses
- (2008) Gail M. Gauvreau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition
- (2008) Ippei Sato et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of potent CCR4 antagonists: Synthesis and structure–activity relationship study of 2,4-diaminoquinazolines
- (2008) Kazuhiro Yokoyama et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Potent CCR4 antagonists: Synthesis, evaluation, and docking study of 2,4-diaminoquinazolines
- (2008) Kazuhiro Yokoyama et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Potent and orally bioavailable CCR4 antagonists: Synthesis and structure–activity relationship study of 2-aminoquinazolines
- (2008) Kazuhiro Yokoyama et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Urea based CCR3 antagonists employing a tetrahydro-1,3-oxazin-2-one spacer
- (2008) T.G. Murali Dhar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Chemokine receptor antagonists: overcoming developmental hurdles
- (2008) Richard Horuk NATURE REVIEWS DRUG DISCOVERY
- Novel anti-inflammatory treatments for asthma
- (2008) Binita Bhowmick et al. Expert Review of Respiratory Medicine
- Synthesis and structure–activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists
- (2007) Ippei Sato et al. BIOORGANIC & MEDICINAL CHEMISTRY
- From rigid cyclic templates to conformationally stabilized acyclic scaffolds. Part I: The discovery of CCR3 antagonist development candidate BMS-639623 with picomolar inhibition potency against eosinophil chemotaxis
- (2007) Joseph B. Santella et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started